Corning Glass Works acquired the company in 1982, grew the business through hundreds of acquisitions and later spun it off as a publicly traded company under the name Quest Diagnostics, at the beginning of 1997. Over the span of 50 years, Quest has developed countless innovative diagnostic information services, with several firsts for clinical laboratory tests in areas such as women's health, genetics, infectious diseases and cancer. Last year, the company was the first commercial laboratory to receive U.S. Food and Drug Administration emergency use authorization for a molecular Zika test. Today, Quest provides thousands of laboratory services, from genetic tests to predict cancer risk to biological tests for diabetes and heart disease, to empower people to take action to improve health outcomes.